T
When DNA Has Nothing to Say, RNA Speaks: How OncoDxRx's PGA Assay Is Rewriting the Rules of Precision Oncology
July 13, 2026
Game-changing gene signature tool accurately predicts how cancer patients will respond to the existing cancer drugs
August 9, 2025
Solving the equations of cancer cell vulnerability
July 30, 2025
Beyond DNA sequencing, the revolutionary OncoDxRx’s MRD monitoring OncoMRD assay delivers on its promises
July 28, 2025
OncoDxRx Reveals New Breakthrough OncoMRD BREAST Test
July 14, 2025
Unprecedented Drug Mapping Technology Provides Clues for Precision Treatment of Non-responders
March 20, 2025
OncoDxRx's precision diagnostics innovations: efficiency, economy and personalization
February 28, 2025
PGA vs. Biomarker Testing: Which Platform Reigns Supreme?
February 22, 2025
Patient-Derived Gene Expression Signatures Are Pioneering Residual Tumor Monitoring
February 14, 2025
A responsibility to patients: close the biomarker testing gap in precision oncology
December 24, 2024
Meet OncoDxRx's PGA: A 21st Century Technology Ahead Of Its Time
December 5, 2024
OncoDxRx's blood test shows the benefits of drug efficacy prediction for non-responders
October 27, 2024
OncoDxRx’s PGA technology accurately predicted drug efficacy in non-responder patients
October 20, 2024
OncoDxRx launches drug response prediction technology for therapeutic non-responders in world first
October 7, 2024
OncoDxRx to personalize off-label cancer drugs for patients who have run out of treatment options
September 18, 2024
New Technology Based on Gene Expression Could Identify Effective Drugs for Non-Responders in Cancer
September 7, 2024
One-Of-A-Kind Technology, PGA, Predicts Drug Response
August 22, 2024
OncoDxRx aims to expand its exclusive liquid biopsy technology into monitoring residual disease
August 18, 2024
PGA and OncoMRD technology breakthroughs, showing the teeth of OncoDxRx’s liquid biopsy umbrella
August 11, 2024
A Gene-to-Drug Renaissance
August 3, 2024
PGA from OncoDxRx gives personalized cancer solutions
July 31, 2024
AI Isn’t the Magic Bullet to Simplify Drug Discovery
June 11, 2024
Personalized cancer treatments based on PGA testing quickly leads to faster treatment, better outcomes
May 15, 2024
PGA helps predict anticancer drug response in a week
March 18, 2024
Employing PGA to Optimize Treatment Selection
February 28, 2024
Method that rapidly predicts drug efficacy clinically validated
February 16, 2024
Innovations and Breakthroughs Shaping OncoDxRx's OncoMRD Technology
December 24, 2023